All kits available are available in small ( SV ) and large ( LV ) sizes, depending on the amount of sample to be processed. This article describes the characteristics and performance of two MagNA Pure 96 DNA and viral nucleic acid kits and methods. Materials and Method Results and discussion Genomic DNA Table 1 : Typical DNA yield and purity Sample type Sample volume DNA yield ( μg ) DNA purity ( OD260/280 ) Kit type blood blood Cultured cells Cultured cells 200 μl 500 μl 5 x 10 5 1 x 10 6 6.6 μg 16.5 μg 10.4 μg 22.0 μg 1.9 2.0 2.0 2.0 SV LV SV LV product Package size Numbering MagNA Pure 96 High-throughput Fully Automatic Nucleic Acid Isolation and Purification System Instruments, controls, software, all accessories 3×96 purifications 05 195 322 001 05 467 497 001 05 467 454 001 05 467 543 001 05 467 535 001
Peanut has
good quality and smell, contains 50% of oil, nearly 30%
protein , 20% sugar. It is mainly edible, can be used in printing & dyeing,
papermaking industry, also make traditional Chinese medicine (TCM), which can cure
malnutrition, spleen and stomach
disorders, cough phlegm, milk lacks, the
bleeding disorder. Its stem and leaves are
high quality feeds.
Peanut Nutritional Aromatic Peanut China Chongqing Pangfanyi Technology Co.,Ltd. , https://www.pangfany.com
Roche Applied Science, Pittsburgh, Germany
* Corresponding author: michael.
Foreword
MagNA Pure 96 was recently entered the market a new device: it is a fully automatic, ultra high-speed system, which can for high-speed high-quality nucleic acid isolated from a variety of sample types, within 1 hour to complete the multi- Automated purification of 96 samples with a sample capacity of up to 1 ml . The system uses an optimized kit with pre-packed ready-to-use reagents and a corresponding automated separation method. The kit's configuration is based on the long-standing magnetic bead technology that has been used successfully for different MagNA Pure systems for many years. The MagNA Pure 96 kit consists of reagent trays with different pre-packed sealed buffer containers and special bottles with magnetic powder.
The new kits and methods were developed and tested using human EDTA plasma, citrate plasma, serum and whole blood, and cultured cells ( K562 and HeLa ) as sample materials.
Whole blood can be used for genomic DNA isolation without pretreatment. The cultured cell pellets are suspended in PBS prior to use.
In the case of viral nucleic acid isolation, different amounts of DNA virus (cytomegalovirus, Epstein-Barr virus, parvovirus B19 ) and RNA virus (hepatitis A virus, influenza A H1N1 influenza virus) are added to the sample before use. Then the samples were pipetted into MagNA Pure 96 on the MagNA Pure instrument 96 in the process cartridge. All samples were tested at least 8 fold replication. The elution volume of the purified nucleic acid was set to 50 μl , 100 μl or 200 μl according to the experimental needs. The eluate was analyzed on an LightCycler® 480 instrument using absorbance ( OD ) assay, agarose gel electrophoresis, and / or parameter-specific quantitative real-time PCR and RT-PCR analysis. The amplification reaction was established using 15 μl of each of the mixed mother liquors and 5 μl of the respective eluates for 45 cycles. 
General characteristics
The composition of the kit: pre-packed reagent containers arranged in the reagent tray for easy loading; separate bottles containing magnetic beads ( MGP ) suspension (Figure 1 ). The reagent tray and bottle are placed in their respective positions in the instrument drawer before they are run. The container can be easily resealed after use and stored for later operation if necessary. The MGP bottle has a special cap that automatically reseals after the needle of the instrument has passed. All components are stable at room temperature.
The MagNA Pure 96 DNA and Viral Nucleic Acid Small Volume Specification is used to isolate genomic DNA from 200 μl whole blood or from 5 x 105 cultured cells. It also isolates viral DNA or RNA from 200 μl of plasma, serum or whole blood. The kit includes 3 pre-filled reagent containers, each of which can perform up to 192 reactions (ie, 576 purifications per kit).
MagNA Pure 96 DNA viral nucleic acid and a kit for large capacities of genomic DNA isolated from 500 μ l or 1000 μ l whole blood or from cultured cells 106. 500 μ l it from plasma, serum or whole blood,
Or viral DNA or RNA isolated from a 1000 μ l plasma or serum. The kit includes 3 pre-filled reagents . Figure 1 : Kit components.
Containers, each for up to 96 reactions (500 μ l) or 48 times the reaction (1000 μ l)
(ie 288 or 144 purifications per kit).
If required, the kit can be used for different optimization methods, including external dissolution methods, allowing for virus inactivation outside of the MagNA Pure 96 instrument. For all methods, nucleic acids can be conveniently eluted from samples of different capacities, and the different capacities of the samples can be selected by the user.
Isolation of genomic DNA and subsequent analysis revealed high reproducibility, yield, integrity and purity. According to agarose gel analysis, the DNA fragments were significantly larger than 20 kb on average (Fig. 2 ).
Figure 2 : Separation of blood
Table 1 summarizes typical DNA yields and purity. Note yield significantly depends on the number of blood cells, and therefore variations may reach twice.
Figure 3 : measurability. Agarose gel analysis of DNA isolated from different amounts of blood showed good quantifiability of the purification method.
Viral nucleic acid linear range
A high yield of purified viral DNA and RNA is achieved. It is possible to isolate viral nucleic acids from a wide range of concentrations (Fig. 4 ).
Figure 4 : Linear range. Separation of Epstein-Barr virus ( EBV ) DNA and Hepatitis A virus RNA at a concentration of 10-10 6 copies was added to each sample .
Internal quality control and repeatability
The MagNA Pure 96 system includes an internal quality control ( IC ) for each separation reaction. The IC is automatically transferred from the on-board IC tube into the lysis buffer in each well. The diluted parvovirus B19 plasmid was used as the IC in all 96 wells of one purification operation, and the negative serum was used as the sample material to examine the function. The separation of ICs is highly reproducible (Figure 5 ).
Figure 5: Internal controls. PCR analysis of parvovirus B19 internal controls isolated from all 96 wells of the treated sample cassette .
Cross contamination test
These tests were conducted to examine the extent of possible inter-well contamination on the MagNA Pure 96 instrument. Parvovirus B19 was selected as a sensitive parameter for these assays; the detection limit was approximately 2.5 copies per PCR . Plasma was then loaded at 5 x 107 copies /ml ( = 106 times above the detection limit) and processed on a MagNA Pure 96 instrument using a bulk method ( 500 μl sample) and a 50 μl elution volume.
Three " checkerboard " runs were performed (every 48 positive spiked plasma samples and 48 negative unloaded plasma samples were arranged in a checkerboard pattern). The eluate was analyzed on a LightCycler® 480 instrument. No cross-contamination was found under these conditions (Fig. 6 ).
Figure 6 : Cross contamination test. Forty- eight positive and 48 negative samples were arranged in a checkerboard shape and processed for cross-contamination analysis. All negative samples were identified as " negative " and all positive samples and all controls showed the expected signal. The test was repeated 3 times and all gave the same results.
" Plasma " and " General " methods
During the optimization of the method, it was found that some sample materials (ie, serum, whole blood, and citrate plasma) gave better results in a different workflow than the " standard " material EDTA plasma. Therefore, in addition to the " Plasma Method of Operation " , another " general operation method " is provided which enables better results for these sample types (up to 5 cross thresholds). The term " general method of operation " was chosen because these methods are superior to " plasma methods " for serum, whole blood, and citrate plasma; and for EDTA plasma, at least for the virus tested (hepatitis A virus, Influenza A ( H1N1 , Epstein-Barr virus, cytomegalovirus) is equivalent to the " method of operation for plasma " . Since the results may vary with individual experimental equipment and the parameters being tested, different methods are available in the instrument's method menu to allow the user to choose the best solution for the application.
in conclusion
The new MagNA Pure 96 DNA and Viral Nucleic Acid Kits provide fully automated and efficient separation of DNA and viral nucleic acids from a wide range of sample materials with high speed and high yield. Users can choose between several different methods depending on their specific needs. In addition, the sample can handle a wide range of sample sizes. Therefore, new kits will be a useful tool for laboratories with large workloads.
MagNA Pure 96 DNA and Viral Nucleic Acid Small Capsule
MagNA Pure 96 DNA and Viral Nucleic Acid Bulk Kit
MagNA Pure 96 Cell RNA Small Capacity Kit
MagNA Pure 96 Cell RNA Bulk Kit
3×192 purifications
3×192 purifications
3×96 purifications
New MagNA Pure 96 Nucleic Acid System - a fast and productive solution
Michael Kirchgesser*, Agnes Aschenbrenner, Irene Huber, Sarah Müller, Heike Girgnhuber, Hubert Schuldlos, Anna Werner, Werner Malmberg, Robert Steiner, Martin Victor, Thomas Kirschbaum, Claudia Kappelsberger, Michael Knoll, and Peter Wenzig
As shown by the dilution experiments prior to PCR performed in the LightCycler® 480 instrument (data not shown), DNA was also shown to be free of PCR inhibitors. The measurability of the procedure was tested with different amounts of blood and samples. The results are shown in Figure 3 .